🔎 Trials Near Me

Beranda › Obesitas › Texas › Houston

Uji klinis Obesitas di Houston, TX

43 studi untuk Obesitas mencari peserta di lokasi sekitar Houston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Menerima pesertaFase 2
  • Juno Research /ID# 282413, Houston
  • PlanIt Research /ID# 282204, Houston
  • JCCT - Juno Bellaire /ID# 282263, Bellaire · 7 mi jauhnya
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07752979

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Menerima pesertaFase 2
  • Cardiovascular Specialists of Willowbrook, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07783802

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Menerima pesertaFase 3
  • PlanIt Research, PLLC, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07533175

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Menerima pesertaFase 3
  • DM Clinical, Houston
Usia 8 hingga 18 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07253285

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Menerima pesertaFase 3
  • Houston Research Institute, Houston
  • The Endocrine Center, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07668414

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Menerima pesertaFase 3
  • PlanIt Research, LLC (Monitoring Room), Houston
  • PlanIt Research, LLC, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07595549

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Menerima pesertaFase 3
  • McGovern Medical School, Houston
  • Texas Childrens Hospital, Houston
  • Dynamed Clinical Research, LP d/b/a DM Clinical Research, Houston
  • dan 1 lainnya
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Menerima pesertaFase 3
  • Juno Research, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Menerima pesertaFase 3
  • Juno Research, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Menerima pesertaFase 3
  • Research Site, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Menerima pesertaFase 3
  • Biopharma Informatic, LLC, Houston
  • Cardiovascular Specialists of Willowbrook, Houston
  • PlanIt Research, PLLC, Houston
  • dan 2 lainnya
Usia 45 hingga 99 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Menerima pesertaFase 3
  • The University of Texas Health Science Center at Houston, Bellaire · 7 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Menerima pesertaFase 3
  • Care Access - Houston, Houston
  • JCCT - Juno Bellaire Site, Bellaire · 7 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Menerima pesertaFase 2
  • PlanIt Research, PLLC, Houston
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07589608

Semaglutide for Post-Smoking Cessation Weight Management

Menerima pesertaFase 2Sukarelawan sehat diterima
  • The University of Texas Health Science Center at Houston, Houston
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Menerima pesertaFase 3
  • AURORA-2 Clinical Site, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Menerima pesertaFase 3
  • East Texas Cardiology PA, Houston
  • Biopharma Informatic, Houston
  • Orion Medical, Houston
  • dan 3 lainnya
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Menerima pesertaFase 3
  • HRI ? Medical Center, LLC, Houston
  • Juno Research, LLC, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Menerima pesertaFase 2
  • Juno Research, Houston
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Menerima pesertaFase 3
  • Elevate Clinical, Houston
  • Houston Research Institute, Houston
  • Bellaire Clinical Research, LLC, Bellaire · 7 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Menerima pesertaFase 3Sukarelawan sehat diterima
  • ACCOMPLISH-2 Research Site, Houston
  • ACCOMPLISH-2 Research Site, Houston
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Menerima pesertaFase 2
  • PlanIt Research, PLLC, Houston
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Menerima pesertaFase 2
  • Biopharma Informatic, LLC, Houston
  • PlanIt Research, PLLC, Houston
  • Research Physicians Network, LLC, Houston
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07215559

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Menerima pesertaFase 4
  • Center for Clinical Studies, Houston
  • Bellaire Dermatology Associates, Bellaire · 7 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT06857942

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Menerima pesertaFase 3
  • JCCT- Juno Northwest Houston, Houston
  • Biopharma Informatic, LLC, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 mi jauhnya
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Menerima pesertaFase 3
  • Kailera Clinical Site, Bellaire · 7 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Menerima pesertaFase 3
  • JCCT- Juno Northwest Houston, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 mi jauhnya
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Menerima pesertaFase 3
  • Biopharma Informatic, LLC, Houston
  • Research Physicians Network, LLC, Houston
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Menerima pesertaFase 3
  • Research Site, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT07784725

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Menerima pesertaFase 2
  • Baylor Texas Children's Hospital, Houston
Usia 7 hingga 25 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Menerima pesertaFase 3
  • East Texas Cardiology PA, Houston
  • Victorium Clinical Research, Houston
  • Main Heart Clinic, Houston
  • dan 1 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Menerima pesertaFase 3
  • ACCOMPLISH-1 Research Site, Houston
  • ACCOMPLISH-1 Research Site, Houston
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07654361

PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents

Menerima pesertaSukarelawan sehat diterima
  • Children's Nutrition Research Center, Houston
Usia 12 hingga 18 · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT06959901

Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents

Menerima pesertaSukarelawan sehat diterimaMenyebutkan pembayaran untuk peserta
  • USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston
Usia 14 hingga 16 · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT06943001

Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Lilli Health, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Mei 2026 · NCT05950282

Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery

Menerima peserta
  • M D Anderson Cancer Center, Houston
Usia 18 ke atas · Wanita · Diperbarui 21 Apr 2026 · NCT04003038

Incretin Microdosing for Cardiometabolic Health in People With HIV

Menerima pesertaFase 2
  • The University of Texas Health Science Center at Houston, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Feb 2026 · NCT07325500

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

Menerima pesertaFase 2
  • Baylor College of Medicine, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Jan 2026 · NCT06273072

RESET System Pivotal Trial (Rev F)

Menerima peserta
  • Baylor College of Medicine, Houston
Usia 22 hingga 65 · Semua jenis kelamin · Diperbarui 18 Jul 2024 · NCT04101669

Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity

Menerima peserta
  • Houston Methodist Hospital, Houston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Apr 2024 · NCT06339320

Uji klinis Obesitas di kota lain

Studi lain di Houston

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.